After reading the excellent series of posts by pjoshea13 on the correlation of systemic inflammation with PCa, I did some Google search and landed on the following 2018 paper:
"Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy".
ncbi.nlm.nih.gov/pmc/articl...
The most important index there, i.e. vested the highest statistical significance, is PNI. Don't confuse it with PNI, aka PeriNeural Invasion, cited in biopsies. It is a totally different thing. It is a weighted sum of serum Albumin and Lymphocytes count. For average normal values of Albumin 4.5 g/dl and 2500 Lymphocytes per μl, or mm^3, the PNI formula gives: 10x4.5 + 0.005x2500 = 45 + 12.5 = 57.5
For a prognosis on biochemical recurrence post-RP the authors state a cutoff value of 47.4 (higher being better).
"Conclusion: High dNLR, high PLR, and low PNI were associated with poor biochemical recurrence-free survival in patients undergoing radical prostatectomy for high-risk localized prostate cancer not treated with neoadjuvant ADT. In particular, PNI was an independent prognostic factor for biochemical recurrence."
Checking my historical data PNI was hovering between 59 and 57 from 2000 to 2015 when my PSA was <2.3. Post-RP, 9 months ago, it has come down to 53.4 - 51.7.
There is also another earlier 2017 paper, for advance PCa titled:
"Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone".